Showing 41 - 60 results of 329 for search '"monoclonal gammopathy of undetermined significance"', query time: 0.14s Refine Results
  1. 41

    Advances in the understanding of IgM monoclonal gammopathy of undetermined significance [version 1; referees: 2 approved] by Jonas Paludo, Stephen M Ansell

    Published 2017-12-01
    “…Among monoclonal gammopathies of undetermined significance (MGUSs), the immunoglobulin M (IgM) MGUS subtype stands as a unique entity and plays a pivotal role as a pre-malignant condition for multiple B-cell non-Hodgkin lymphomas, most notably Waldenström macroglobulinemia (WM). …”
    Get full text
    Article
  2. 42

    PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW by A. A. Yakovlev, E. S. Tarabanova, A. G. Smochilin, R. A. Gapeshin, M. V. Yakovleva

    Published 2017-09-01
    “…Monoclonal gammopathy of undetermined significance represents a number of conditions, the development of which is based on functional impairment of B-lymphocytes, which results in permanent pathological secretion of a single clone of immunoglobulins or their constituent chains. …”
    Get full text
    Article
  3. 43

    Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance by Maira A. Castañeda-Avila PhD, Kate L. Lapane PhD, Sharina D. Person PhD, Bill M. Jesdale PhD, Yanhua Zhou MS, Kathleen M. Mazor EdD, Mara M. Epstein ScD

    Published 2022-09-01
    “…Introduction This study evaluated the impact of receiving a monoclonal gammopathy of undetermined significance (MGUS) diagnosis on healthcare utilization from patients at a community-based multispecialty provider organization. …”
    Get full text
    Article
  4. 44
  5. 45

    Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients by Widad Tahiru, Antonio Izarra Santamaria, Johan Hultdin, Wendy Yi-Ying Wu, Florentin Späth

    Published 2022-02-01
    “…Abstract Follow-up of low-risk monoclonal gammopathy of undetermined significance (MGUS) is debated as multiple myeloma (MM) progression risk is low. …”
    Get full text
    Article
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50

    A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea by Ka-Won Kang, Ji Eun Song, Byung-Hyun Lee, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Yong Park, Byung Soo Kim

    Published 2021-09-01
    “…Abstract In clinical practice, most patients with monoclonal gammopathy of undetermined significance (MGUS) undergo long-term follow-up without disease progression. …”
    Get full text
    Article
  11. 51

    Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma by Wilson I. Gonsalves, Katarzyna Broniowska, Erik Jessen, Xuan-Mai Petterson, Alexander Graham Bush, Jaimee Gransee, Martha Q. Lacy, Taro Hitosugi, Shaji K. Kumar

    Published 2020-06-01
    “…Abstract Oncogenic drivers of progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) such as c-MYC have downstream effects on intracellular metabolic pathways of clonal plasma cells (PCs). …”
    Get full text
    Article
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58

    The “Undetermined Significance” of <sup>18</sup>F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) by Giorgio Treglia, Francesco Bertagna, Domenico Albano

    Published 2021-08-01
    “…Monoclonal gammopathy of undetermined significance (MGUS) is a highly prevalent condition with the possible risk of progression to multiple myeloma (MM) or a lymphoproliferative neoplasm in a small percentage of patients. …”
    Get full text
    Article
  19. 59
  20. 60